Exploring the therapeutic potential of apabetalone in diabetic kidney disease: Bridging preclinical findings with clinical translation
Pharmacological Research · 2024
DOI: 10.1016/j.phrs.2024.107362 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pharmacological Research, 2024. Verfasst von Honglian Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Puai Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Puai Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
- Puai Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: shenwei1971@126.com.
- Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: s2023003010@pumc.edu.cn.
Zitieren
APA
Luo, H., Yao, Y., Wang, W., Shen, W., & Zhao, G. (2024). Exploring the therapeutic potential of apabetalone in diabetic kidney disease: Bridging preclinical findings with clinical translation. Pharmacological Research. https://doi.org/10.1016/j.phrs.2024.107362
Vancouver
Luo H, Yao Y, Wang W, Shen W, Zhao G. Exploring the therapeutic potential of apabetalone in diabetic kidney disease: Bridging preclinical findings with clinical translation. Pharmacological Research. 2024. doi:10.1016/j.phrs.2024.107362
BibTeX
@article{Luo2024,
author = {Luo, Honglian and Yao, Yi and Wang, Wenhua and Shen, Wei and Zhao, Guo},
title = {Exploring the therapeutic potential of apabetalone in diabetic kidney disease: Bridging preclinical findings with clinical translation},
journal = {Pharmacological Research},
year = {2024},
doi = {10.1016/j.phrs.2024.107362}
}
EUVIMED